Variant report
Variant | nsv965795 |
---|---|
Chromosome Location | chr6:26855844-26857981 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GUSBP2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375238771 | chr6:26855859-26855860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375069479 | chr6:26855865-26855866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368399861 | chr6:26855875-26855876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547325993 | chr6:26855883-26855884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570294809 | chr6:26855913-26855914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539273779 | chr6:26855941-26855942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555962636 | chr6:26855988-26855989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs62400809 | chr6:26856030-26856031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376414984 | chr6:26856040-26856041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201856569 | chr6:26856060-26856061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535545313 | chr6:26856083-26856084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141974550 | chr6:26856085-26856086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs199541548 | chr6:26856093-26856094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572054459 | chr6:26856107-26856108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182368039 | chr6:26856130-26856131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115289317 | chr6:26856141-26856142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201768797 | chr6:26856150-26856151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538557145 | chr6:26856162-26856163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558523873 | chr6:26856193-26856194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs199665365 | chr6:26856214-26856215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs578201042 | chr6:26856231-26856232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556169873 | chr6:26856234-26856235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563924822 | chr6:26856300-26856301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574012689 | chr6:26856328-26856329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200098442 | chr6:26856381-26856382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377208568 | chr6:26856385-26856386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs62400810 | chr6:26856417-26856418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543112299 | chr6:26856439-26856440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577713383 | chr6:26856515-26856516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528518717 | chr6:26856523-26856524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544735458 | chr6:26856577-26856578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9379941 | chr6:26856590-26856591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187084582 | chr6:26856598-26856599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77338385 | chr6:26856600-26856601 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
35 | rs578248587 | chr6:26856609-26856610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371940580 | chr6:26856610-26856611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564008494 | chr6:26856613-26856614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572090937 | chr6:26856616-26856617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191136575 | chr6:26856620-26856621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533073462 | chr6:26856693-26856694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549524068 | chr6:26856695-26856696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569834967 | chr6:26856707-26856708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183571031 | chr6:26856740-26856741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549102846 | chr6:26856744-26856745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200250695 | chr6:26856852-26856853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200882041 | chr6:26856889-26856890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534630876 | chr6:26856972-26856973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9885950 | chr6:26856983-26856984 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs62400811 | chr6:26857010-26857011 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs578241981 | chr6:26857034-26857035 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26838000-26866200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr6:26838800-26857600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:26841400-26866200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:26844400-26856000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr6:26844400-26865800 | Weak transcription | Ovary | ovary |
6 | chr6:26844400-26872000 | Weak transcription | Fetal Intestine Small | intestine |
7 | chr6:26844600-26857600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr6:26844800-26857800 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
9 | chr6:26845000-26864200 | Weak transcription | Pancreas | Pancrea |
10 | chr6:26849200-26866800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
11 | chr6:26849400-26866600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:26849800-26864200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr6:26850400-26865000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr6:26852000-26866200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr6:26852200-26856200 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
16 | chr6:26852200-26857400 | Weak transcription | Liver | Liver |
17 | chr6:26853600-26864000 | Weak transcription | Fetal Stomach | stomach |